Chargement en cours...
Careful dose modification of apatinib as third or further-line treatment in advanced gastric cancer patients with poor performance status
The retrospective study was conducted to evaluate the efficacy and safety of careful dose modification of apatinib as third or further-line treatment in advanced gastric cancer (aGC) patients with poor performance status (PS = 2 or 3). Patients with aGC of poor PS who had received at least 2 lines o...
Enregistré dans:
| Publié dans: | Medicine (Baltimore) |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Wolters Kluwer Health
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6855580/ https://ncbi.nlm.nih.gov/pubmed/31702665 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000017890 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|